Patents expiring in 2031

US 8067563

Tumor suppressor gene, p471NG3

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067473

Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067606

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067219

Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide

Xenon Pharmaceuticals Inc. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067530

Scytovirin domain 1 related polypeptides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067355

Benefit agent containing delivery particles

Appleton Papers Inc. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8066985

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067445

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067505

Method of preparing carboxylic acid functionalized polymers

Nektar Therapeutics · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067466

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

Esperion Therapeutics, Inc. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067460

5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel

The Regents of the University of California · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067453

Neurotrophin production/secretion promoting agent

Takeda Pharmaceutical Company Limited · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067431

Chemically modified small molecules

Nektar Therapeutics · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067030

Controlled release composition and method of producing the same

Takeda Pharmaceutical Company Limited · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067416

Methods and compositions for the treatment of metabolic disorders

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067417

Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067439

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067423

Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067377

Peptide compositions for targeting adipose tissue

The Board of Regents of the University of Texas System · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067390

Therapeutic targeting of interleukins using siRNA in neutral liposomes

The Board of Regents of the University of Texas System · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067237

Scaffolds for cell transplantation

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067202

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067089

Cationic microcapsule particles

Appleton Papers Inc. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8067636

Dihydrazide compounds, preparation and uses thereof

Bioregen Biomedical (Shanghai) Co., Ltd · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2011293661

VACCINE STRAINS OF BRACHYSPIRA HYODYSENTERIAE

HAMPSON DAVID J [AU] · Granted Thu Dec 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071545

Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism

Lewis S. Coleman, MD, Inc. · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071678

Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

Nektar Therapeutics · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071692

Multi-arm block copolymers as drug delivery vehicles

Nektar Therapeutics · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071638

Solid states of atorvastatin potassium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071645

Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors

The Regents of the University of Colorado · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071766

HSP90 inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071618

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071323

Human monoclonal antibodies that bind human insulin like growth factors and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071087

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071746

Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID No. 3

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071807

Antagonists of prostaglandin D2 receptors

Panmira Pharmaceuticals, LLC · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8070467

Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

Aphios Corporation · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071084

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071074

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071130

Solid preparation

Takeda Pharmaceutical Company Limited · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071118

Method of inducing cell proliferation using fibroin

UNIVERSITY OF CONNECTICUT · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071109

VMP-like sequences of pathogenic Borrelia

The Board of Regents of the University of Texas System · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071113

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071137

Method for treatment of cartilage disorders with centella extract

Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071107

Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins

The Regents of the University of California · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071380

Skeletal muscle periangioblasts and cardiac mesangioblasts, method for isolation and uses thereof

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071535

Guanidinium derivatives for improved cellular transport

The Regents of the University of California · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8071556

Peptide substance revealing a stress protective effect, pharmaceutical composition on its base, and the method of its application

Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)